StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic fDA MAUDE Adverse Event Reports — Medtronic Total

U.S. FDA openFDA Manufacturer & User Facility Device Experience (MAUDE)

QuarterlyAnnualMonthly
Latest, Q1 FY27
97,049
Period ended Jul 31, 2026
Change on a year earlier
+18.8%
81,659 in Q1 FY26
History
51 quarters
Since Q3 FY14
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFDA MAUDE Adverse Event Reports — Medtronic TotalYear on yearSource
Q1 FY27Jul 31, 202697,049+18.8%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY26Apr 30, 2026104,151+57.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY26Jan 31, 202684,369+13.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY26Oct 31, 2025101,865+50.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY26Jul 31, 202581,659+18.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY25Apr 30, 202566,228+3.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY25Jan 31, 202574,539+5.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY25Oct 31, 202467,798-8.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY25Jul 31, 202469,110+8.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY24Apr 30, 202464,204-12.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY24Jan 31, 202470,949-21.5%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY24Oct 31, 202373,691+20.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY24Jul 31, 202363,824-52.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY23Apr 30, 202373,737-16.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY23Jan 31, 202390,351+103.8%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY23Oct 31, 202261,189+22.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗

Breakdown

What makes up fda maude adverse event reports — medtronic total

Cite this data

StockData. (2026). Medtronic FDA MAUDE Adverse Event Reports — Medtronic Total, quarterly Q3 FY14–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ext-fda-maude-tot

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.